miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate NSCLC cell proliferation and apoptosis and is a potential biomarker and therapeutic target for NSCLC [147]. Here, YY1 is linked to non-small cell lung carcinoma.